Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and many other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 18.3 days after submission; acceptance to publication is undertaken in 6.9 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Special Issue in Antibodies
Antibody Discovery and Optimization Using Ribosome Display Antibody Presentation and Optimization Platform Guest Editor: Adinarayana Kunamneni
Deadline: 31 December 2021
Special Issue in Antibodies
Advances in the Application of Antibodies and Autoantibodies in the Treatment of Autoimmune Blistering Diseases Guest Editor: Kyle T. Amber
Deadline: 15 February 2022
Special Issue in Antibodies
CAR-T Cell Metabolism Guest Editor: Roddy O'Connor
Deadline: 28 February 2022
Special Issue in Antibodies
Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections Guest Editors: Luis Martinez-Sobrido, James J. Kobie
Deadline: 20 March 2022
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop